AstraZeneca Concedes Blood Clotting Concerns from Oxford/AstraZeneca (ChAdOx1-S) Vaccine
A British High Court case filed by victims of blood clots caused by the AstraZeneca Oxford COVID-19 vaccine has the media buzzing over a company admission to a serious blood clotting condition called VITT or vaccine induced thrombocytopenic purpura.
Kindly click here to see the video
Here is an excerpt from the Daily Mail April 30, 2024:
“We may never know the true number of people laid low by a rare but devastating complication related to AstraZeneca‘s Covid jab, lawyers representing families have told MailOnline.
Fifty-one families are currently pursuing legal action against the pharmaceutical titan, arguing its ‘defective’ jab was to blame for their injuries and deaths of loved ones.
Called thrombosis with thrombocytopenia syndrome (TSS) or alternatively vaccine-induced immune thrombotic thrombocytopenia (VITT) the complication caused dangerous, and potential deadly, blood clots to form in the body.”
On America First with former White House Advisor Sebastian Gorka, PhD, I review the totality of medical literature on this horrific condition setting the stage to understand the continued legal battle for the British who are seeking justice from their own once prideful product, the “Oxford Vaccine.”
While all COVID-19 vaccines and SARS-CoV-2 infection itself cause blood clots because the Spike protein induced hemagglutination and thrombus formation, the AstraZeneca Oxford ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vector vaccine in which the vector itself is associated with clotting.
The VITT syndrome is associated with a determinant, platelet factor 4, a product of adenoviral vector/Spike autoimmunity that pins platelet to the blood vessel wall causing clotting and bleeding at the same time. These among many problems were the basis for non-approval of the AstraZeneca vaccine in the United States and its removal from markets worldwide.
See more here Substack
Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company 
incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Trackback from your site.
Tom
| #
Does this mean they will stop marketing and selling this crap? No! Likely they will increase their efforts to inject us to death with these poisons.
Reply
Cal Aylmer
| #
Actually they’re gonna make sure we take it by force if necessary in Quebec Canada the flash of the 666 from the minister and here we go
( nothing satanic happening here lol ) >
FORCED VACCINATION SLIPPED INTO QUEBEC PUBLIC HEALTH ACT..
https://www.bitchute.com/video/3rmz837ikanP/
Reply
Wisenox
| #
They are liable:
Item II of the EUA requirements was willfully disregarded on many counts. Known risks were listed in test packet fact sheets, and the patents are loaded with them. Moderna alone has 10 patents under covid EUA with more than 550 patent citations included. To say that there are no known risks is absurd. They’re in a patent infringement lawsuit with Pfizer, and GSK is mad that companies are using their mNeon green reporter gene in their poly-A tail ribosomal frameshifting technologies. Is mNeon green being used as a targeting marker or a reporter?
21 USC 360bbb-3: Authorization for medical products for use in emergencies
A) Required Conditions
(ii) Appropriate conditions designed to ensure that individuals to whom the product is administered are informed-
(I) that the Secretary has authorized the emergency use of the product;
(II) of the significant known and potential benefits and risks of such use, and of the extent to which such benefits and risks are unknown; and
(III) of the option to accept or refuse administration of the product, of the consequences, if any, of refusing administration of the product, and of the alternatives to the product that are available and of their benefits and risks.
Reply